-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Bing Z Carter, PhD1, Po Yee Mak1*, Hong Mu, MD, PhD1*, Duncan Mak1*, Ej Dettman2*, Michael Cardone2*, Xiangmeng Wang, PhD1*, Wendy Schober1*, Wenjing Tao1*, Takahiko Seki3* and Michael Andreeff, MD, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Eutropics, Cambridge, MA
3DaiichiSankyo Co., Ltd., Tokyo, Japan

Chun Shik Park, PhD1*, Ye Shen, Ph.D.1*, Andrew H Lewis, BS1, Koramit Suppipat, MD1*, Monica Puppi1*, Julie Tomolonis2*, Taylor J Chen1*, Paul Pang3*, Toni-Ann Mistretta1*, Leyuan Ma4*, Michael R Green, PhD5*, Rachel E. Rau, MD6 and H. Daniel Lacorazza, PhD1

1Baylor College of Medicine Texas Children's Hospital, Houston, TX
2Baylor College of Medicine, Houston, TX
3Baylor College of Medicine, houston, TX
4University of Massachusetts Medical School, Worcester, MA
5Molecular Cell and Cancer Biology, UMass Medical School, Worcester, MA
6Texas Childrens Hospital, Houston, TX

Preetesh Jain, MBBS, MD, DM, PhD1, Rashmi Kanagal-Shamanna, MD2, Hagop M. Kantarjian, MD3, F. Anthony San Lucas4*, Ahmad Ghorab, MD, MSc4*, Elias J. Jabbour, MD 5, Issa Ghayas6*, Koji Sasaki, MD7, Tapan Kadia, MD8, Zeev Estrov, MD9, Farhad Ravandi, MBBS10 and Jorge E. Cortes, MD3

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas, The MD Anderson Cancer Center, HOUSTON
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4University of Texas, The MD Anderson Cancer Center, Houston
5University of Texas M.D. Anderson Cancer Ctr., Houston, TX
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
7The University of Texas MD Anderson Cancer Center, Houston, TX
8M.D. Anderson Cancer Center, Houston, TX
9University of Texas M.D. Anderson Cancer Center, Houston, TX
10Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Anna M. Eiring, PhD1, Jonathan Ahmann1*, Clinton C. Mason, PhD2*, Ethan Dmitrovsky, MD3*, Thomas O'Hare, PhD4 and Michael W. Deininger, MD, PhD4

1Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
2Department of Pediatrics, The University of Utah, Salt Lake City, UT
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT

Dehuan Ji1*, Pengshan Zhang1*, Wenjuan Ma1*, Xiuyan Zhang1*, Haixia Zhou, MD, PhD2*, Yun Zhao, PhD3* and Li Zhu, MD, PhD1

1Cyrus Tang Hematology Center, Soochow University, Suzhou, China
2the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China
3Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, China

Olatundun Williams, MD1,2, Elizabeth Hjort, PhD1*, Ling Bei, MD1*, Liping Hu, PhD1* and Elizabeth A. Eklund, MD1,3,4

1Northwestern University Feinberg School of Medicine, Chicago, IL
2Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
3Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
4Jesse Brown Veterans Affairs Medical Center, Chicago, IL

Filomena Daraio, PhD1*, Emilia Giugliano1*, Carmen Fava, MD, PhD1*, Roberta Lorenzatti, Dr.1*, Marta Varotto, Dr.2*, Davide Barberio, Dr.2*, Simona Bernardi, PhD3*, Barbara Izzo, PhD4*, Santa Errichiello, PhD4*, Maria Teresa Bochicchio5*, Claudia Venturi, Dr.5*, Francesco Albano, MD6*, Giuseppe Saglio, MD, PhD1, Fabrizio Pane, MD7, Giovanni Martinelli, MD8, Giorgina Specchia, MD6, Domenico Russo, MD3 and Enrico Marco Gottardi, Dr.1*

1Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
2Bioclarma s.r.l. Research and Molecular Diagnostics, Turin, Italy
3Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
4Department of Clinical Medicine and Surgery- University of Naples “Federico II” - CEINGE-Biotecnologie Avanzate Napoli-Italy, Naples, Italy
5Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, "S. Orsola-Malpighi" Hospital, Bologna, Italy
6University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
7Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
8Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “L. and A. Seragnoli”, University of Bologna, Bologna, Italy

Seung Hun Han, PhD1*, Soo-Hyun Kim2*, Kim Hyoung-June, PhD3*, Lee Yoonsung, PhD4*, Soo Young Choi2*, Park Gyeongsin5*, Kim Do-Hyun6*, Lee Aram7*, Kim Jongmin, PhD7*, Choi Je-Min, PhD6*, Kim Yonghwan, PhD7*, Myung Kyungjae, PhD8*, Kim Hongtae, PhD3* and Dong-Wook Kim, MD, PhD9

1Department of Biological Sciences, Sungkyunkwan University, Suwon, Korea, Republic of (South)
2Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Sungkyunkwan University, Suwon, Korea, Republic of (South)
4Center for Genomic Integrity Institute for Basic Science (IBS), Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of (South)
5Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Hanyang University, Seoul, Korea, Republic of (South)
7Sookmyung Women’s University, Seoul, Korea, Republic of (South)
8Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of (South)
9Catholic Blood and Marrow Transplantation Center, Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Min Young Lee, MD, PhD1*, Chan-jeoung Park, MD1*, Young-Uk Cho1*, Eunkyoung You1*, Seongsoo Jang, MD1, Chang Ahn Seol1*, Eul-Ju Seo, MD1* and Jung-Hee Lee, MD, PhD2*

1Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
2Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

*signifies non-member of ASH